objectives To systematically review reasons for the willingness to participate in biomedical human subjects research in low-and middle-income countries (LMICs).
Introduction
Ample studies have addressed the willingness of human subjects to participate in biomedical research. Some studies focused on ethical aspects, looking into voluntary informed consent and the relation between participants' motivations and the level of voluntariness that they display. Others looked into practical aspects in an attempt to understand barriers for research participation and improve recruitment and retention rates [1] [2] [3] [4] . Studies on the willingness to participate include research in specific populations such as pregnant women or children with cancer, ethnic minorities, and in varying contexts in high as well as low-and middle-income countries (LMICs) [2, [5] [6] [7] [8] [9] . Systematic reviews on willingness to participate are rare [7, 10] , and do not exist for research participation in LMICs specifically. At the same time, these reviews are highly relevant for research conducted in LMICs since social determinants such as poverty, limited health care access, illiteracy and linguistic or cultural aspects may *Joint first authors.
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influence the willingness to participate and affect the understanding of research concepts such as randomisation, research risks and voluntariness [11] [12] [13] [14] [15] . A better understanding of the motives of those who participate could improve informed consent processes, incorporating a culturally competent approach, and inform ethical guidelines for the design and conduct of health-related human subjects research. We therefore aim to systematically review reasons for the willingness to participate in human subjects biomedical research in LMICs.
Methods

Eligibility criteria
Articles were eligible for inclusion in this systematic review if they related to the domain of biomedical research involving human beings in LMICs (as defined by the World Bank) and addressed 'reasons to (not) participate' [16] . Articles were included if published after the year 2000, following amendments in the guidelines for research ethics in low-resource settings [17] . Articles were excluded if they concerned secondary analysis or were not published in English or Dutch.
Data search
A systematic search of the electronic databases PubMed, Embase, Cochrane Library, Popline and GHL (Global Health Library) was conducted to include all articles up to June 27 th , 2017. A search string involving relevant key words and possible variations was constructed based on the domain (human subjects research in LMIC) and determinant (reasons for (non-) participation, see Appendix S1).
Study selection
Studies were screened for title and abstract based on the eligibility criteria independently by two reviewers (CR and JB). Reasons for exclusion were registered. Discordance of article relevance between reviewers (CR and JB) was discussed and resolved, with full-text articles being assessed and a third reviewer (RvdG) consulted if necessary. If the full-text article was not available online, one attempt was made to contact the author, and if no response was received the article was excluded.
Data collection
Data extraction of the articles was performed by two reviewers (CR and JB) for the following items: authors, year of publication, original study design, indication (disease), country, participants, study design of the nested study, aim of derived study, reasons identified and generic reasons identified. 'Original study design' referred to the type of research of which the willingness to participate was investigated, 'nested study' referred to at which point the 'willingness to participate' in research was investigated (hypothetical, prospective or retrospective). 'Generic reasons' were the groupings of individually different reasons given in relevant articles.
Data items
The various reasons for and against participation were classified into categories as defined in Table 1 . Categories were defined by the authors (JB, CR, RvdG) after data extraction, based on themes derived from previously published similar reviews [18] .
Data synthesis
The analysis aimed to provide an overall ranking of frequency of reasons for participation and the relative importance of reasons compared to others in two steps. First, it was assessed whether a reason was listed in an article. Subsequently, for the papers that provided ranking information with regard to relative importance of reasons, the order of the top three reasons was determined. Given the heterogeneity of methods to determine relative ranking of reasons across studies, the ranking as reported in each of the studies was used.
Thus, three rankings were created: (i) the absolute frequency a reason was listed in the articles, (ii) the frequency a reason was ranked in the top three, (iii) and how many times a reason was ranked as most important. A descriptive composite ranking of importance was subsequently created based on these three categories, in an attempt to globally suggest which reasons may be the most important.
For papers that did not provide information on the relative importance of a reason compared to others, the article was only considered for the absolute number of times a reason was mentioned.
Ranking of reasons were stratified for the following categories, if available in more than one article: World regions (as defined by the World Bank, with the regions of 'South Asia' and 'East and Asia & Pacific' combined into 'Asia'), male vs. female, non-patient vs. patients, HIV research vs. non-HIV research (due to the hypothesis possibility that stigmatisation could influence research participation, particularly in HIV research) and hypothetical (i.e. empirical studies that ask participants about 
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potential participation in studies that do not (yet) exist or enrol participants) vs. 'real' studies [16] . 'Real' studies (i.e. empirical studies nested in research for which participants were recruited/enrolled in) could either be prospective or retrospective. An article was categorised into a specific region by study location. If a paper concerned multiple countries or regions, the information specific to individual regions was extracted.
Quality assessment
Owing to the nature of the research question for this review, the risk of bias for included studies was not investigated. The protocol for this systematic review was registered in the PROSPERO database (CRD42015017126).
Results
The search across all databases yielded a total of 1243 results of which 987 unique articles remained after removal of duplicates. One hundred and forty-four articles were screened in full-text, resulting in 94 articles included in this systematic review. Figure 1 presents study selection flow diagram. Table S1 presents an overview of included articles, the characteristics of which are summarised in Table 2 . The majority of articles (n = 54) reported both reasons for and against participation in research. Most were hypothetical (n = 64), and all were qualitative (n = 44) or mixed methods (n = 50). The majority of articles reported on studies about specific diseases, most commonly infectious diseases. Most studies were conducted in sub-Saharan Africa (n = 45), followed by Asia (n = 27), Latin America and the Caribbean (n = 11), the Middle East and North Africa (n = 4) and Eastern Europe (n = 2). Table 3 presents the frequency a reason for (non-)participation was mentioned in studies, the number of times ranked as a reason in the top three, and the number of times ranked as top reason. Fifty-five studies included information on the relative importance of reasons mentioned. Table 4 provides the composite summary of relative importance. Table S2 provides ranking  of reason per article, Table S3 the number of times a reason was listed, and Tables S4-8 ranking by different population characteristics. Figures S1-S13 visualise the data provided here.
Reasons most frequently mentioned and indicated as relatively most important within studies in favour of participation, were altruism, personal health benefits, access to health care, monetary benefit, knowledge, social support and trust. Overall, these were common across LMICs in different regions, real and hypothetical studies, for both HIV and non-HIV research, for men and women and for non-patient and patient participants (Tables 3, 4 ; Figures S1-13). [27, 69] . Several studies stated that monetary benefit was one of the less important influencing factors in participation [35, 38] , it being ranked fourth overall in importance. This was ranked as the third most important reason in HIV and non-HIV research, was ranked fourth for the regions of SubSaharan Africa, Asia and Eastern Europe, and for patient and non-patient participants, male and female participants and for real and hypothetical studies. It was ranked fifth for South and Latin America, and ninth for North Africa and the Middle East.
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Knowledge
The gaining of knowledge through research participation was mentioned 16 times overall, [25, 27, 41, 44, 54, 59, 60, 62, 67, 73, 76, 81, 82, [86] [87] [88] ranked in the top three reasons four times, [44, 59, 67, 88] and was given as the top reason in one paper to participate [44] . Knowledge was ranked fifth in Sub-Saharan Africa and Eastern Europe, in Table 3 Frequency reasons for and against participation in human subjects research were mentioned in included studies (n = 94) [20, 32, 36, 69, 78] , and ranked sixth overall. Social support seemed to play a larger role in Asia than in other regions. Furthermore, it appeared to be slightly more important for HIV research than non-HIV research (being ranked sixth and seventh in these categories, respectively). There was no difference between male and female participants' perspective (or between real and hypothetical studies) of social support as a reason for participation, but was more important for patients than non-patient participants. However, a few articles suggested that the influence of family and friends was more important for women ([46] , [78] While the reason of 'trust' was ranked seventh overall, it was ranked higher (fourth) for research in South and Latin America and North Africa and the Middle East, as well as for non-HIV research, patient participants and for real studies (ranked fifth).
Reasons for participation
Reasons for non-participation 9 Mentioned (n = 73) 9 Top 3 (n = 41) 9 Top Reason (n = 41) 9 Mentioned (n = 71) 9 Top 3 (n = 47) 9 Top Reason (n = 47) Ability to withdraw 1 1 0 Confidentiality concerns 12 4 3 Access to Health Care 42 20 4 Costs 5 3 1 Altruism 46 30 20 Cultural insensitivity 2 2 0 Advice from physician 4 2 0 Distrust 14 4 0 Community involvement 5 2 Efficacy concerns 12 10 2 Convenience 3 0 0 False-positive test results 8 4 1 Cultural acceptability 2 1 1 Lack of social support 23 11 3 Feeling of community 1 Fear of health status 5 3 0 Personal health
Other reasons for participation
Additional reasons for participation mentioned were: ability to withdraw [91] , advice from physician [20, 27, 77, 85] , community involvement [34, [61] [62] [63] 66] , cultural acceptability [63, 91] , creating a feeling of community [44] , low pressure decision [75] , need for treatment [77] , research involving a non-invasive procedure [46, 81] , peer enrolment [33, 44, 84] , low perception of risk [54, 70] , result availability [20] , guarantee of confidentiality [23, 33, 34, 62] , being unaware of voluntariness of participation [46] , research outcome, [60, 62, 66, 84] and finally seeing research participation as motivation to avoid risky behaviour [59] .
The most important reasons for non-participation were safety concerns, inconvenience, stigmatisation, lack of social support, confidentiality concerns, physical pain, efficacy concerns and distrust. Overall, these were common across different regions, real and hypothetical studies, HIV and non-HIV research, men and women and non-patient and patient participants (Tables 4-5, S1-13).
Safety concerns
Safety concerns were the most often mentioned reason for non-participation. This was a particular issue for vaccine or drug trials, but not for observational studies. Safety concerns were mentioned in 45 papers [1, 20- [31, 32, 40, 45, 47, 48, 55, 58, 61, 65, 68, 71, 77, 93, 94, 96, 98] . Safety concerns were consistently ranked as most important in all categories, with the exception of North Africa and the Middle East, where they ranked second. In some articles, it was explicitly mentioned that women were generally more 'worried about complications' [27] .
Inconvenience
Inconvenience was mentioned in 25 articles as a reason for non-participation [20, 28, 30-32, 34, 37, 42, 44, 46, 50, 51, 54, 58, 67, 69, 71, 100-106] , ranked as the top three reasons fourteen times [31, 44, 46, 50, 54, 67, 69, 71, 100-102, 104, 106] , and ranked first in four articles [67, 101, 102, 104] . Examples of inconveniences included not having enough time to participate in research, transport issues or a long distance to the research site [67, 71] . 
Confidentiality concerns
Confidentiality concerns were mentioned 12 times [20-22, 43, 44, 46, 58, 86, 91, 107] , ranked in the top three, four times [21, 44, 46, 91] , and ranked first, three times [44, 46, 91] . Confidentiality concerns were ranked highest by research participants in North Africa and the Middle East (second), even though it was ranked fifth overall. This reason was not assigned the same importance for Eastern Europe or South and Latin America, or for HIV research. Furthermore, they seemed more important for male participants than female participants, and were also more important for patient participants over non-patient participants and hypothetical over real studies.
Physical pain
(Fear of) physical pain was mentioned as a reason 13 times [19, 20, 28, 31, 44, 47, 50, 53-55, 76, 83, 105] , ranked in the top three to five times [19, 20, 31, 47, 105] , and given as the most important reason twice [19, 47] . It seemed to be slightly more important for male participants, patient participants, for non-HIV research, and research participants in Sub-Saharan Africa. For South and Latin America this reason was least cited.
Efficacy concerns
Efficacy concerns were mentioned 12 times, [36, 40, 45, 47, 51-53, 59, 77, 92, 97, 98] ranked in the top three ten times [36, 40, 45, 47, 51, 52, 59, 77, 97, 98] , and ranked first twice [59, 97] . This was of the most importance for research conducted in Asia, and in HIV research. For men and studies conducted in Eastern Europe, South and Latin America and North Africa and the Middle East, it was a less important reason.
Distrust
Distrust was mentioned in 14 articles [21, 34, 37, 39, 41, 42, 45, 53, 55, 56, 58, 62, 83] , and given as a top three reason four times [41, 56, 58, 61] . Distrust was an important factor mostly in Eastern Europe, and was ranked as the eighth most important reason overall.
Other reasons for non-participation
Additional reasons given for non-participation were costs [44, 58, 69, 103, 111] , cultural insensitivity [37, 101] , fear of false-positive test results after participation in HIV research [36, 44, 45, 50, 59, 86, 93, 94] , fear of knowledge of health status [19, 28, 30, 54, 68] , insufficient compensation [21, 43] , invasive procedures, [1, 20, 30, 39, 54, 78, 87, 106] lack of interest [30, 34, 37, 61, 86, 95, 102, 104, 105, 109] , lack of clarity [1, 30, 37, 51, 52, 91, 111] , not willing to comply to terms of research [55, 68, 93, 106, 108] , no perceived need [29, 53, 55, 65, 98] , feeling overwhelmed [109] , placebo concerns [29, 40, [52] [53] [54] [55] , having had a previous negative experience [75, 111] , not wishing to be re-contacted [91] , feeling tempted to unsafe behaviour [43] , lack of perceived benefit [92] , effect on lifestyle [20, 53] , worsening medical condition, [99, 100, 102] and having a lack of knowledge about research [26, 55, 56, 75, 88, 95, 101] .
Discussion
This systematic review shows that the most important reasons for willingness to participate in research (altruism, personal health benefits and access to health care) or not (safety concerns, inconvenience, stigmatisation and lack of social support) are common across LMICs in different regions, for both HIV and non-HIV research, for men and women and for non-patient and patient participants. Research professionals and ethics committees addressing the interests of LMICs (study) populations can use the results from this review to prepare for and conduct research in these environments. Some of the reasons identified in this review could influence the voluntary decision to participate in research. For example, (expected) personal or community health benefits, access to health care, (dis)trust or community pressure could affect autonomy in the consent to participate in research, or de facto constitute controlling influences affecting autonomy [15, 112] .
As many of the reasons to (not) participate are linked to socio-economic factors relatively common in LMIC contexts (such as poverty and illiteracy), the complete removal of these influences seems unrealistic for study investigators. Literature and international ethical guidelines for research conduct [14] mention a number of ways that could help to mitigate the potential threats of these reasons to participate to voluntary informed consent. Simultaneously, barriers to research identified in this review, such as need for/lack of social support, fear of stigmatisation, inconvenience and therapeutic misconception can also be addressed using these approaches [112, 113] .
First, community engagement, in which the role of the family and community (leaders) in decision making is acknowledged and incorporated [112] . Community engagement addresses the importance of (expected) personal and/or community benefit in the decision to participate in research, and can enhance the understanding of research [112] . The 2016 CIOMS International Ethical Guidelines for Health-related Research Involving Humans similarly recommend to engage communities when conducting (clinical) research in low-resource settings to ensure ethical and scientific quality [14] .
Second, the potentially inappropriate influence of reasons to (not) participate on voluntary consent could be attenuated by balancing the decision to participate in research against a person's expressed values in the consent process [15] . This 'threshold inquiry' assesses whether the (potential) participant would also have participated in the absence of these influences and as such not persuade, coerce or manipulate a person into participation. Importantly, these influences are potentially -but not by definition inappropriate. Thus, a threshold inquiry allows for an assessment of whether the inducement for trial participation (e.g. access to health care) is sufficiently weighted against the risk the person assumes, and as such does not result in 'poor judgement which makes us take unnecessary, unreasonable and excessive risks of harm, whether physical harm or the harm of violating important values' -as there is nothing 'unethical or wrong when individuals considering entering a trial weigh the inducement against the risk they will assume' [114] .
Therefore, the third manner in which potential influences could be addressed is to incorporate procedures in informed consent processes that safeguard the understanding of the nature and implications of the research. Various existing strategies can be employed, including sufficient time for subjects to consider their participation and discuss it with family and friends; and provision of adequate information about what research entails (about research in general and the specific research in particular) from someone without a dependency relationship (such as between physician and patient) ( [4, 15] , [112] ).
Previous reviews of reasons for research participation have been conducted for specific LMIC populations, healthy volunteers in predominantly high-resource settings and specific subpopulations in high-resource settings. Reviews summarising studies conducted in Brazil, India and China, similarly identified the importance of altruism, personal benefit and access to health [2, 9] . Overall, participation in human subjects research seems an effort of subjects to improve their personal or community's circumstances, and this effort generally outweighs monetary gain in importance [7, 9, [115] [116] [117] . This contrasts with a review of reasons among healthy volunteers to participate in clinical trials in mainly high-resource settings (United States (n studies = 6), Portugal, Spain, the Netherlands, Croatia, Germany, United Kingdom and Malawi (all n = 1), in which financial rewards were reported a primary motivation to participate -albeit altruistic motives informed the decision as well [118] . For specific (patient) populations in high-resource settingschildren and their parents participating in drug research, women with breast cancer, cancer patients and minority populations in the United States -altruism and access to health care were (more) important considerations in the decision to participate in research [5] [6] [7] [8] 118] .
The major reasons for non-participation -concern for safety; distrust of research or health professionals; privacy concerns, and a fear of social consequences -were also reported by previous reviews in LMICs, highresource settings and among specific subpopulations [7, 9, 115, 119] .
To the best of our knowledge, this is the first systematic review to investigate motivations that influence willingness to participate across LMICs as a whole. As we stratified our results by various study characteristics, the results can be generalised to a wide scope of human subjects research. The comprehensive inclusion of study designs, both qualitative and quantitative methods, is a strength of this study.
This review, however, has limitations that should be considered when interpreting the findings. First, the method by which the importance of reasons for participation was determined may not yield indisputable results, as a standardised methodology of ranking of reasons of (non-) participation is not available. We aimed to provide a structured overview with a ranking of relative importance, a quantitative improvement over previously published reviews [9] . Second, a majority of studies included were hypothetical (64 out of 94), and the extent to which these reflect real life situations may vary. Nonetheless, the ranking of reasons for (non-)participation between hypothetical and 'real' studies yielded similar results. We did not look specifically into the difference in reasons to participate based on the method of data collection (e.g. interview vs. self-administered questionnaire) or study design (e.g. observational vs. interventional research). It is possible that differences in reasons for (non-) participation could be found between these groups. Furthermore, the paucity of data of studies from North Africa, the Middle East and Eastern Europe, as well as from noninfectious disease research, limits the generalisability of the results to these domains. The same can be said about the fact that we limited relevant articles to those written in the Dutch or English language, meaning literature written in other languages common to LMIC (i.e. French, Spanish) was not taken into account in these reviews.
This review identified a number of research needs for global health (research) ethics. First, a standardised way to collect data on reasons for (non-)participation in research and synthesis of preferences would allow for better comparison and analysis of data across studies. This would eliminate many of the limitations identified for this review. Ideally, these tools could help researchers to assess motivators and barriers to conduct of the study in the feasibility or piloting stage. Second, given potential similarities in the reasons to (not) participate between LMICs populations and disadvantaged populations in high-income countries resulting from socio-economic disadvantage, further research into the reasons for (non-) participation in these groups may be of value, including systematic synthesis of the body of literature up to now. Similarly, very few reviews included (potentially) marginalised or hard-to-reach populations in LMICs such as (ethnic) minority groups or members of the LGBT community.
The main motivations to participate in human subject research in LMICs are altruism, a desire for personal health benefits, and access to health care. Safety concerns, inconvenience, a lack of social support and -for HIVrelated studies -stigmatisation are the major reasons for non-participation in these populations. In order to ensure voluntary consent to participation and reduce barriers for potential participants, these reasons for (non-) participation should be considered in the planning and conduct of research.
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